{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:41:52Z","timestamp":1790800912850,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.ppat.1006935","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T00:00:00Z","timestamp":1521158400000}}],"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T00:00:00Z","timestamp":1520294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1006935","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T18:34:38Z","timestamp":1520361278000},"page":"e1006935","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":70,"title":["Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies"],"prefix":"10.1371","volume":"14","author":[{"given":"Harrison G.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9508-411X","authenticated-orcid":true,"given":"Tina","family":"Ritschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8017-8201","authenticated-orcid":true,"given":"Gabriel","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Just P. J.","family":"Brakenhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1986-7387","authenticated-orcid":true,"given":"Elissa","family":"Keogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Furmanova-Hollenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9330-9423","authenticated-orcid":true,"given":"Ellen","family":"Lanckacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehangir S.","family":"Wadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan S. A.","family":"Gilman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6391-6540","authenticated-orcid":true,"given":"R. Anthony","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Roymans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3705-2392","authenticated-orcid":true,"given":"Ang\u00e9lique B.","family":"van \u2018t Wout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8768-0982","authenticated-orcid":true,"given":"Johannes P.","family":"Langedijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3991-542X","authenticated-orcid":true,"given":"Jason S.","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,3,6]]},"reference":[{"issue":"6","key":"ref1","first-page":"543","article-title":"Risk of primary infection and reinfection with respiratory syncytial virus","volume":"140","author":"WP Glezen","year":"1986","journal-title":"Am J Dis Child"},{"issue":"17","key":"ref2","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"AR Falsey","year":"2005","journal-title":"N Engl J Med"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMoa0804877","article-title":"The burden of respiratory syncytial virus infection in young children","volume":"360","author":"CB Hall","year":"2009","journal-title":"N Engl J Med"},{"issue":"10098","key":"ref4","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study","volume":"390","author":"T Shi","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants","volume":"102","year":"1998","journal-title":"Pediatrics"},{"key":"ref6","first-page":"571609","article-title":"Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World Perspective","author":"N Homaira","year":"2014","journal-title":"Int J Pediatr"},{"key":"ref7","first-page":"83","article-title":"Structure and function of respiratory syncytial virus surface glycoproteins","volume":"372","author":"JS McLellan","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"issue":"309","key":"ref8","doi-asserted-by":"crossref","first-page":"309ra162","DOI":"10.1126\/scitranslmed.aac4241","article-title":"Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera","volume":"7","author":"JO Ngwuta","year":"2015","journal-title":"Sci Transl Med"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"e02357","DOI":"10.1128\/JVI.02357-16","article-title":"Broadly Reactive Anti-Respiratory Syncytial Virus G Antibodies from Exposed Individuals Effectively Inhibit Infection of Primary Airway Epithelial Cells","volume":"91","author":"B Cortjens","year":"2017","journal-title":"J Virol"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/jmv.20349","article-title":"Comparison of affinity chromatography and adsorption to vaccinia virus recombinant infected cells for depletion of antibodies directed against respiratory syncytial virus glycoproteins present in a human immunoglobulin preparation","volume":"76","author":"P Sastre","year":"2005","journal-title":"J Med Virol"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/viro.2001.1138","article-title":"Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo","volume":"289","author":"MN Teng","year":"2001","journal-title":"Virology"},{"issue":"25","key":"ref12","doi-asserted-by":"crossref","first-page":"13961","DOI":"10.1073\/pnas.94.25.13961","article-title":"Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: Clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant","volume":"94","author":"RA Karron","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"ref13","doi-asserted-by":"crossref","first-page":"12608","DOI":"10.1128\/JVI.79.19.12608-12613.2005","article-title":"Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates","volume":"79","author":"S Biacchesi","year":"2005","journal-title":"J Virol"},{"issue":"23","key":"ref14","doi-asserted-by":"crossref","first-page":"12877","DOI":"10.1128\/JVI.78.23.12877-12887.2004","article-title":"Recombinant human Metapneumovirus lacking the small hydrophobic SH and\/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate","volume":"78","author":"S Biacchesi","year":"2004","journal-title":"J Virol"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1128\/JVI.65.6.2773-2777.1991","article-title":"Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusion","volume":"65","author":"A Moscona","year":"1991","journal-title":"J Virol"},{"issue":"Pt 2","key":"ref16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1099\/0022-1317-72-2-439","article-title":"Measles virus: both the haemagglutinin and fusion glycoproteins are required for fusion","volume":"72","author":"TF Wild","year":"1991","journal-title":"J Gen Virol"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0042-6822(91)90162-5","article-title":"The fusion and hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus 3 are both required for fusion","volume":"183","author":"SN Ebata","year":"1991","journal-title":"Virology"},{"issue":"Pt 9","key":"ref18","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1099\/0022-1317-68-9-2521","article-title":"Demonstration That Glycoprotein-G Is the Attachment Protein of Respiratory Syncytial Virus","volume":"68","author":"S Levine","year":"1987","journal-title":"J Gen Virol"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1128\/JVI.68.7.4538-4546.1994","article-title":"The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons","volume":"68","author":"SR Roberts","year":"1994","journal-title":"J Virol"},{"issue":"Pt 6","key":"ref20","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1099\/0022-1317-68-6-1705","article-title":"Appearance of a soluble form of the G protein of respiratory syncytial virus in fluids of infected cells","volume":"68","author":"DA Hendricks","year":"1987","journal-title":"J Gen Virol"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1006\/viro.1996.0379","article-title":"Host cell effect upon glycosylation and antigenicity of human respiratory syncytial virus G glycoprotein","volume":"221","author":"R Garcia-Beato","year":"1996","journal-title":"Virology"},{"issue":"Pt 4","key":"ref22","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1099\/0022-1317-73-4-849","article-title":"Oligomerization and post-translational processing of glycoprotein G of human respiratory syncytial virus: altered O-glycosylation in the presence of brefeldin A","volume":"73","author":"PL Collins","year":"1992","journal-title":"J Gen Virol"},{"issue":"21","key":"ref23","doi-asserted-by":"crossref","first-page":"7795","DOI":"10.1093\/nar\/13.21.7795","article-title":"Respiratory Syncytial Virus Envelope Glycoprotein (G) Has a Novel Structure","volume":"13","author":"M Satake","year":"1985","journal-title":"Nucleic Acids Research"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1073\/pnas.82.12.4075","article-title":"Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein","volume":"82","author":"GW Wertz","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"ref25","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1073\/pnas.84.16.5625","article-title":"The G-Glycoprotein of Human Respiratory Syncytial Viruses of Subgroup-A and Subgroup-B\u2014Extensive Sequence Divergence between Antigenically Related Proteins","volume":"84","author":"PR Johnson","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1099\/0022-1317-77-6-1249","article-title":"Proposed three-dimensional model for the attachment protein G of respiratory syncytial virus","volume":"77","author":"JP Langedijk","year":"1996","journal-title":"J Gen Virol"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.vaccine.2016.09.045","article-title":"Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development","volume":"35","author":"JA Melero","year":"2017","journal-title":"Vaccine"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/pro.5560060619","article-title":"Determination of the disulfide bond arrangement of human respiratory syncytial virus attachment (G) protein by matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry","volume":"6","author":"JJ Gorman","year":"1997","journal-title":"Protein Sci"},{"issue":"8","key":"ref29","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/90675","article-title":"CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein","volume":"2","author":"RA Tripp","year":"2001","journal-title":"Nat Immunol"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"e0130517","DOI":"10.1371\/journal.pone.0130517","article-title":"CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent Manner","volume":"10","author":"KI Jeong","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"e1005318","DOI":"10.1371\/journal.ppat.1005318","article-title":"Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures","volume":"11","author":"SM Johnson","year":"2015","journal-title":"PLoS Pathog"},{"issue":"24","key":"ref32","doi-asserted-by":"crossref","first-page":"13466","DOI":"10.1128\/JVI.01741-13","article-title":"Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses","volume":"87","author":"T Chirkova","year":"2013","journal-title":"J Virol"},{"issue":"Pt 9","key":"ref33","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1099\/vir.0.000218","article-title":"CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells","volume":"96","author":"T Chirkova","year":"2015","journal-title":"J Gen Virol"},{"issue":"47","key":"ref34","doi-asserted-by":"crossref","first-page":"14684","DOI":"10.1021\/bi9621627","article-title":"Solution structure of the immunodominant region of protein G of bovine respiratory syncytial virus","volume":"35","author":"JF Doreleijers","year":"1996","journal-title":"Biochemistry"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1034\/j.1399-3011.2002.21027.x","article-title":"Structure-antigenicity relationship studies of the central conserved region of human respiratory syncytial virus protein G","volume":"60","author":"M Sugawara","year":"2002","journal-title":"J Pept Res"},{"issue":"8","key":"ref36","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1128\/JVI.73.8.6610-6617.1999","article-title":"Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G","volume":"73","author":"SA Feldman","year":"1999","journal-title":"J Virol"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/viro.2000.0293","article-title":"Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection","volume":"271","author":"LK Hallak","year":"2000","journal-title":"Virology"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/JVI.79.2.1113-1124.2005","article-title":"Infection of Ciliated Cells by Human Parainfluenza Virus Type 3 in an In Vitro Model of Human Airway Epithelium","volume":"79","author":"L Zhang","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1165\/rcmb.2013-0360OC","article-title":"Effects of anti-G and anti-F antibodies on airway function after respiratory syncytial virus infection","volume":"51","author":"J Han","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.4049\/jimmunol.0901373","article-title":"Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients","volume":"183","author":"EJ Collarini","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"e34331","DOI":"10.1371\/journal.pone.0034331","article-title":"The respiratory syncytial virus G protein conserved domain induces a persistent and protective antibody response in rodents","volume":"7","author":"TN Nguyen","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1128\/JVI.01755-09","article-title":"Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice","volume":"84","author":"W Zhang","year":"2010","journal-title":"J Virol"},{"issue":"3","key":"ref43","first-page":"193","article-title":"Antibodies to the central conserved region of respiratory syncytial virus (RSV) G protein block RSV G protein CX3C-CX3CR1 binding and cross-neutralize RSV A and B strains","volume":"25","author":"Y Choi","year":"2012","journal-title":"Viral Immunol"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1128\/JCM.23.3.475-480.1986","article-title":"Identification of epitopes on respiratory syncytial virus proteins by competitive binding immunoassay","volume":"23","author":"LJ Anderson","year":"1986","journal-title":"J Clin Microbiol"},{"issue":"13","key":"ref45","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.1073\/pnas.1110203109","article-title":"In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo","volume":"109","author":"R Villenave","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(00)80438-9","article-title":"Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion","volume":"91","author":"T Imai","year":"1997","journal-title":"Cell"},{"issue":"6226","key":"ref47","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.aaa5026","article-title":"Structural biology. Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor","volume":"347","author":"JS Burg","year":"2015","journal-title":"Science"},{"issue":"30","key":"ref48","doi-asserted-by":"crossref","first-page":"23187","DOI":"10.1074\/jbc.M002584200","article-title":"The crystal structure of the chemokine domain of fractalkine shows a novel quaternary arrangement","volume":"275","author":"DM Hoover","year":"2000","journal-title":"Journal of Biological Chemistry"},{"issue":"Pt 11","key":"ref49","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1099\/0022-1317-70-11-2953","article-title":"Comparison of antigenic sites of subtype-specific respiratory syncytial virus attachment proteins","volume":"70","author":"EE Walsh","year":"1989","journal-title":"J Gen Virol"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/600108","article-title":"Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB\/c mice","volume":"200","author":"LM Haynes","year":"2009","journal-title":"J Infect Dis"},{"issue":"Pt 5","key":"ref51","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1099\/vir.0.009308-0","article-title":"Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab&apos;)2 components mediates reduced pulmonary inflammation in mice","volume":"90","author":"C Miao","year":"2009","journal-title":"J Gen Virol"},{"issue":"19","key":"ref52","doi-asserted-by":"crossref","first-page":"11611","DOI":"10.1128\/JVI.01726-14","article-title":"Structural Insights into the Human Metapneumovirus Glycoprotein Ectodomain","volume":"88","author":"C Leyrat","year":"2014","journal-title":"J Virol"},{"key":"ref53","unstructured":"PATH. RSV Vaccine and mAb Snapshot 2017. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.path.org\/vaccineresources\/details.php?i=1562\" xlink:type=\"simple\">http:\/\/www.path.org\/vaccineresources\/details.php?i=1562<\/ext-link>."},{"issue":"138","key":"ref54","first-page":"138ra181","article-title":"Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies","volume":"4","author":"X Qiu","year":"2012","journal-title":"Sci Transl Med"},{"issue":"408","key":"ref55","doi-asserted-by":"crossref","first-page":"eaao4235","DOI":"10.1126\/scitranslmed.aao4235","article-title":"Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail","volume":"9","author":"B Julg","year":"2017","journal-title":"Sci Transl Med"},{"issue":"22","key":"ref56","doi-asserted-by":"crossref","first-page":"10508","DOI":"10.1128\/JVI.74.22.10508-10513.2000","article-title":"Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection","volume":"74","author":"LK Hallak","year":"2000","journal-title":"J Virol"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41467-017-00170-x","article-title":"Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor","volume":"8","author":"D Roymans","year":"2017","journal-title":"Nat Commun"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"e01456","DOI":"10.7554\/eLife.01456","article-title":"Collaboration gets the most out of software","volume":"2","author":"A Morin","year":"2013","journal-title":"Elife"},{"issue":"4","key":"ref59","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"MD Winn","year":"2011","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"4","key":"ref60","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1107\/S0907444910048675","article-title":"iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM","volume":"67","author":"TG Battye","year":"2011","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"7","key":"ref61","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1107\/S0907444913000061","article-title":"How good are my data and what is the resolution?","volume":"69","author":"PR Evans","year":"2013","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"4","key":"ref62","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"AJ McCoy","year":"2007","journal-title":"J Appl Crystallogr"},{"issue":"Pt 12 Pt 1","key":"ref63","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"P Emsley","year":"2004","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"Pt 2","key":"ref64","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"PD Adams","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"3","key":"ref65","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"E Krissinel","year":"2007","journal-title":"J Mol Biol"},{"key":"ref66","unstructured":"Schrodinger, LLC. The PyMOL Molecular Graphics System, Version 1.8. 2015."}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1006935","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T00:00:00Z","timestamp":1521158400000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1006935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T01:40:52Z","timestamp":1603935652000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1006935"}},"subtitle":[],"editor":[{"given":"Ted C.","family":"Pierson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,6]]},"references-count":66,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1006935","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.ppat.1006935","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,6]]}}}